NCT00282178View on ClinicalTrials.gov

Double-Blind Randomized Cross-Over Trial Comparing Metabolic Effects of Candesartan, Hydrochlorothiazide and Placebo

PHASE2CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

April 30, 2005

Primary Completion Date

March 31, 2006

Study Completion Date

April 30, 2006

Conditions
HypertensionObesity
Interventions
DRUG

Hydrochlorothiazide

25-50 mg once daily

DRUG

Placebo

Once daily

DRUG

Candesartan

16-32 mg once daily 12 weeks

Trial Locations (1)

SE-90185

Umeå University Hospital, Umeå

Sponsors

Collaborators (1)

AstraZeneca
All Listed Sponsors
collaborator

Sahlgrenska University Hospital

OTHER

collaborator

AstraZeneca

INDUSTRY

lead

Umeå University

OTHER